Bifidobacteria and butyrate-producing colon bacteria: Importance and strategies for their stimulation in the human gut

Frontiers in Microbiology

Volumn 7, Issue JUN, 2016, Pages

  Rivière, Audrey ^a   Selak, Marija ^a   Lantin, David ^a   Leroy, Frédéric ^a   De Vuyst, Luc ^a  

^a VRIJE UNIVERSITEIT BRUSSEL   (Belgium)

Author keywords

Arabinoxylan oligosaccharides; Bifidobacteria; Butyrate producing colon bacteria; Cross feeding; Inulin type fructans; Prebiotics; Probiotics

Indexed keywords

ARABINOXYLAN; BUTYRIC ACID; FRUCTAN; INULIN; LINOLEIC ACID; OLIGOSACCHARIDE; PREBIOTIC AGENT; PROBIOTIC AGENT; VITAMIN B GROUP;

ALLERGY; ANTIBIOTIC ASSOCIATED DIARRHEA; AUTISM; BIFIDOBACTERIUM; COLON FLORA; GENE AMPLIFICATION; HOMEOSTASIS; HUMAN; INFLAMMATORY BOWEL DISEASE; IRRITABLE COLON; MICROBIAL COMMUNITY; MICROBIAL DEGRADATION; MICROBIAL METABOLISM; NONHUMAN; OBESITY; POLYMERASE CHAIN REACTION; REVIEW;

EID: 84980335892     PISSN: None     EISSN: 1664302X     Source Type: Journal    
DOI: 10.3389/fmicb.2016.00979     Document Type: Review

References (189)

1. Al-Lahham, S. H., Peppelenbosch, M. P., Roelofsen, H., Vonk, R. J., and Venema, K. (2010). Biological effects of propionic acid in humans; metabolism, potential applications and underlying mechanisms. Biochim. Biophys. Acta 1801, 1175-1183. doi: 10.1016/j.bbalip.2010.07.007
2. Antoine, C., Peyron, S., Mabille, F., Lapierre, C., Bouchet, B., Abecassis, J., et al. (2003). Individual contribution of grain outer layers and their cell wall structure to the mechanical properties of wheat bran. J. Agric. Food Chem. 51, 2026-2033. doi: 10.1021/jf0261598
3. Aroniadis, O. C., and Brandt, L. J. (2014). Intestinal microbiota and the efficacy of fecal microbiota transplantation in gastrointestinal disease. Gastroenterol. Hepatol. 10, 230-237.
4. Arumugam, M., Raes, J., Pelletier, E., Le Paslier, D., Yamada, T., Mende, D. R., et al. (2011). Enterotypes of the human gut microbiome. Nature 473, 174-180. doi: 10.1038/nature09944
5. Bäckhed, F., Ley, R. E., Sonnenburg, J. L., Peterson, D. A., and Gordon, J. I. (2005). Host-bacterial mutualism in the human intestine. Science 307, 1915-1920. doi: 10.1126/science.1104816
6. Barron, C., Surget, A., and Rouau, X. (2007). Relative amounts of tissues in mature wheat (Triticum aestivum L.) grain and their carbohydrate and phenolic acid composition. J. Cereal Sci. 45, 88-96. doi: 10.1016/j.jcs.2006.07.004
7. Belenguer, A., Duncan, S. H., Calder, A. G., Holtrop, G., Louis, P., Lobley, G. E., et al. (2006). Two routes of metabolic cross-feeding between Bifidobacterium adolescentis and butyrate-producing anaerobes from the human gut. Appl. Environ. Microbiol. 72, 3593-3599. doi: 10.1128/AEM.72.5.3593-3599.2006
8. Belenguer, A., Holtrop, G., Duncan, S. H., Anderson, S. E., Calder, A. G., Flint, H. J., et al. (2011). Rates of production and utilization of lactate by microbial communities from the human colon. FEMS Microbiol. Ecol. 77, 107-119. doi: 10.1111/j.1574-6941.2011.01086.x
9. Benamrouche, S., Crônier, D., Debeire, P., and Chabbert, B. A. (2002). A chemical and histological study on the effect of (1 → 4)-β-endo-xylanase treatment on wheat bran. J. Cereal Sci. 36, 253-260. doi: 10.1006/jcrs.2001.0427
10. Bindels, L. B., Delzenne, N. M., Cani, P. D., and Walter, J. (2015). Towards a more comprehensive concept for prebiotics. Nat. Rev. Gastroenterol. Hepatol. 12, 303-310. doi: 10.1038/nrgastro.2015.47
11. Boets, E., Houben, E., Windey, K., De Preter, V., Moens, F., Gomand, S., et al. (2013). "In vivo evaluation of bacterial cross-feeding in the colon using stable isotope techniques: a pilot study, "in Digestive Disease Week, Orlando, FL. Gastroenterology 144.
12. Bottacini, F., Ventura, M., van Sinderen, D., and O'Connell Motherway, M. (2014). Diversity, ecology and intestinal function of bifidobacteria. Microb. Cell Fact. 13, S4. doi: 10.1186/1475-2859-13-S1-S4
13. Braniste, V., Al-Asmakh, M., Kowal, C., Anuar, F., Abbaspour, A., Tóth, M., et al. (2014). The gut microbiota influences blood-brain barrier permeability in mice. Sci. Transl. Med. 6, 263ra158. doi: 10.1126/scitranslmed.3009759
14. Broekaert, W. F., Courtin, C., and Delcour, J. (2009). (Arabino)xylan Oligosaccharide Preparation. WO 2009117790 A2. PCT International Publication.
15. Broekaert, W. F., Courtin, C. M., Verbeke, K., Van de Wiele, T., Verstraete, W., and Delcour, J. A. (2011). Prebiotic and other health-related effects of cereal-derived arabinoxylans, arabinoxylan-oligosaccharides, and xylooligosaccharides. Crit. Rev. Food Sci. Nutr. 51, 178-194. doi: 10.1080/10408390903044768
16. Bunzel, M., Ralph, J., Marita, J. M., Hatfield, R. D., and Steinhart, H. (2001). Diferulates as structural components in soluble and insoluble cereal dietary fibre. J. Sci. Food Agric. 81, 653-660. doi: 10.1002/jsfa.861
17. Cani, P. D., Bibiloni, R., Knauf, C., Waget, A., Neyrinck, A. M., Delzenne, N. M., et al. (2008). Changes in gut microbiota control metabolic endotoxemia-induced inflammation in high-fat diet-induced obesity and diabetes in mice. Diabetes 57, 1470-1481. doi: 10.2337/db07-1403
18. Cani, P. D., and Van Hul, M. (2015). Novel opportunities for next-generation probiotics targeting metabolic syndrome. Curr. Opin. Biotechnol. 32, 21-27. doi: 10.1016/j.copbio.2014.10.006
19. Chang, P. V., Hao, L., Offermanns, S., and Medzhitov, R. (2014). The microbial metabolite butyrate regulates intestinal macrophage function via histone deacetylase inhibition. Proc. Natl. Acad. Sci. U.S.A. 111, 2247-2252. doi: 10.1073/pnas.1322269111
20. Chassard, C., Goumy, V., Leclerc, M., Del'homme, C., and Bernalier-Donadille, A. (2007). Characterization of the xylan-degrading microbial community from human faeces. FEMS Microbiol. Ecol. 61, 121-131. doi: 10.1111/j.1574-6941.2007.00314.x
21. Choi, J. H., Lee, K. M., Lee, M. K., Cha, C. J., and Kim, G. B. (2014). Bifidobacterium faecale sp. nov., isolated from human faeces. Int. J. Syst. Evol. Microbiol. 64, 3134-3139. doi: 10.1099/ijs.0.063479-0
22. Cloetens, L., Broekaert, W. F., Delaedt, Y., Ollevier, F., Courtin, C. M., Delcour, J. A., et al. (2010). Tolerance of arabinoxylan-oligosaccharides and their prebiotic activity in healthy subjects: a randomised, placebo-controlled cross-over study. Br. J. Nutr. 103, 703-713. doi: 10.1017/S0007114509992248
23. Collins, S. M., Surette, M., and Bercik, P. (2012). The interplay between the intestinal microbiota and the brain. Nat. Rev. Microbiol. 10, 735-742. doi: 10.1038/nrmicro2876
24. Courtin, C. M., Broekaert, W. F., Swennen, K., Aerts, G., Van Craeyveld, V., and Delcour, J. A. (2009). Occurrence of arabinoxylo-oligosaccharides and arabinogalactan peptides in beer. J. Am. Soc. Brew. Chem. 67, 112-117. doi: 10.1094/asbcj-2009-0323-01
25. Crittenden, R., Karppinen, S., Ojanen, S., Tenkanen, M., Fagerstrom, R., Matto, J., et al. (2002). In vitro fermentation of cereal dietary fibre carbohydrates by probiotic and intestinal bacteria. J. Sci. Food Agric. 82, 781-789. doi: 10.1002/jsfa.1095
26. Cui, B., Li, P., Xu, L., Peng, Z., Xiang, J., He, Z., et al. (2016). Step-up fecal microbiota transplantation (FMT) strategy. Gut Microbes. doi: 10.1080/19490976.2016.1151608. [Epub ahead of print].
27. Damen, B., Verspreet, J., Pollet, A., Broekaert, W. F., Delcour, J. A., and Courtin, C. M. (2011). Prebiotic effects and intestinal fermentation of cereal arabinoxylans and arabinoxylan oligosaccharides in rats depend strongly on their structural properties and joint presence. Mol. Nutr. Food. Res. 55, 1862-1874. doi: 10.1002/mnfr.201100377
28. Delgado, S., Cabrera-Rubio, R., Mira, A., Suárez, A., and Mayo, B. (2013). Microbiological survey of the human gastric ecosystem using culturing and pyrosequencing methods. Microb. Ecol. 63, 763-772. doi: 10.1007/s00248-013-0192-5
29. de Vos, W. M. (2013). Fame and future of faecal transplantations-developing next-generation therapies with synthetic microbiomes. Microb. Biotechnol. 6, 316-325. doi: 10.1111/1751-7915.12047
30. de Vos, W. M., and de Vos, E. A. (2012). Role of the intestinal microbiome in health and disease: from correlation to causation. Nutr. Rev. 1, S45-S56. doi: 10.1111/j.1753-4887.2012.00505.x
31. De Vuyst, L., and Leroy, F. (2011). Cross-feeding between bifidobacteria and butyrate-producing colon bacteria explains bifidobacterial competitiveness, butyrate production, and gas production. Int. J. Food Microbiol. 149, 73-80. doi: 10.1016/j.ijfoodmicro.2011.03.003
32. De Vuyst, L., Moens, F., Selak, M., Rivière, A., and Leroy, F. (2014). Summer meeting 2013: growth and physiology of bifidobacteria. J. Appl. Microbiol. 116, 477-491. doi: 10.1111/jam.12415
33. Di Gioia, D., Aloisio, I., Mazzola, G., and Biavati, B. (2014). Bifidobacteria: their impact on gut microbiota composition and their applications as probiotics in infants. Appl. Microbiol. Biotechnol. 98, 563-577. doi: 10.1007/s00253-013-5405-9
34. Dinan, T. G., Stanton, C., and Cryan, J. F. (2013). Psychobiotics: a novel class of psychotropic. Biol. Psychiat. 74, 720-726. doi: 10.1016/j.biopsych.2013.05.001
35. Dinan, T. G., Stilling, R. M., Stanton, C., and Cryan, J. F. (2015). Collective unconscious: how gut microbes shape human behavior. J. Psychiat. Res. 63, 1-9. doi: 10.1016/j.jpsychires.2015.02.021
36. Dodd, D., and Cann, I. K. (2009). Enzymatic deconstruction of xylan for biofuel production. Glob. Change Biol. Bioenergy 18, 2-17. doi: 10.1111/j.1757-1707.2009.01004.x
37. Dodd, D., Mackie, R., and Cann, I. K. (2011). Xylan degradation, a metabolic property shared by rumen and human colonic Bacteroidetes. Mol. Microbiol. 79, 292-304. doi: 10.1111/j.1365-2958.2010.07473.x
38. Duncan, S. H., and Flint, H. J. (2013). Probiotics and prebiotics and health in ageing populations. Maturitas 75, 44-50. doi: 10.1016/j.maturitas.2013.02.004
39. Duncan, S. H., Louis, P., and Flint, H. J. (2004). Lactate-utilizing bacteria, isolated from human feces, that produce butyrate as a major fermentation product. Appl. Environ. Microbiol. 70, 5810-5817. doi: 10.1128/AEM.70.10.5810-5817.2004
40. Duncan, S. H., Louis, P., Thomson, J. M., and Flint, H. J. (2009). The role of pH in determining the species composition of the human colonic microbiota. Environ. Microbiol. 11, 2112-2122. doi: 10.1111/j.1462-2920.2009.01931.x
41. Eeckhaut, V., Ducatelle, R., Sas, B., Vermeire, S., and Van Immerseel, F. (2014). Progress towards butyrate-producing pharmabiotics: Butyricicoccus pullicaecorum capsule and efficacy in TNBS models in comparison with therapeutics. Gut 63, 367. doi: 10.1136/gutjnl-2013-305293
42. Eeckhaut, V., Machiels, K., Perrier, C., Romero, C., Maes, S., Flahou, B., et al. (2013). Butyricicoccus pullicaecorum in inflammatory bowel disease. Gut 62, 1745-1752. doi: 10.1136/gutjnl-2012-303611
43. EFSA (2010). Scientific opinion on the substantiation of health claims related to live yoghurt cultures and improved lactose digestion (ID 1143, 2976), pursuant to Article 13 (1) of regulation (EC) No 1924/20061. EFSA J. 8, 1763. doi: 10.2903/j.efsa.2010.1763
44. EFSA (2011a). Scientific opinion on the substantiation of health claims related to resistant starch and reduction of post-prandial glycaemic responses (ID 681), "digestive health benefits" (ID 682) and "favours a normal colon metabolism" (ID 783) pursuant to Article 13 (1) of Regulation (EC) No 1924/2006. EFSA J. 9, 2024. doi: 10.2903/j.efsa.2011.2024
45. EFSA (2011b). Scientific opinion on the substantiation of health claims related to arabinoxylan produced from wheat endosperm and reduction of post-prandial glycaemic responses (ID 830) pursuant to Article 13 (1) of Regulation (EC) No 1924/2006. EFSA J. 9, 2205. doi: 10.2903/j.efsa.2011.2205
46. EFSA (2015). Scientific opinion on the substantiation of a health claim related to "native chicory inulin" and maintenance of normal defecation by increasing stool frequency pursuant to Article 13.5 of Regulation (EC) No 1924/2006. EFSA J. 13, 3951. doi: 10.2903/j.efsa.2015.3951
47. Egan, M., O'Connell Motherway, M., Kilcoyne, M., Kane, M., Joshi, L., Ventura, M., et al. (2014). Cross-feeding by Bifidobacterium breve UCC2003 during co-cultivation with Bifidobacterium bifidum PRL2010 in a mucin-based medium. BMC Microbiol. 14:282. doi: 10.1186/s12866-014-0282-7
48. Ehrmann, M. A., Korakli, M., and Vogel, R. F. (2003). Identification of the gene for beta-fructofuranosidase of Bifidobacterium lactis DSM10140T and characterization of the enzyme expressed in Escherichia coli. Curr. Microbiol. 46, 391-397. doi: 10.1007/s00284-002-3908-1
49. El Aidy, S., Van den Abbeele, P., Van de Wiele, T., Louis, P., and Kleerebezem, M. (2013). Intestinal colonization: how key microbial players become established in this dynamic process. Bioessays 35, 913-923. doi: 10.1002/bies.201300073
50. El Kaoutari, A., Armougom, F., Gordon, J. I., Raoult, D., and Henrissat, B. (2013). The abundance and variety of carbohydrate-active enzymes in the human gut microbiota. Nat. Rev. Microbiol. 11, 497-504. doi: 10.1038/nrmicro3050
51. Eloe-Fadrosh, E. A., Brady, A., Crabtree, J., Drabek, E. F., Ma, B., Mahurkar, A., et al. (2015). Functional dynamics of the gut microbiome in elderly people during probiotic consumption. MBio 6:e00231. doi: 10.1128/mBio.00231-15
52. European Commission (2008). Commission directive 2008/100/EC. Official Journal European Union, p. L 285/9.
53. Euzéby, J. P. (1997). List of bacterial names with standing in nomenclature: a folder available on the internet. Int. J. Syst. Bacteriol. 47, 590-592. doi: 10.1099/00207713-47-2-590
54. Euzéby, J. P. (2016). "Bifidobacterium". List of Prokaryotic Names with Standing in Nomenclature. Available online at: http://www.bacterio.net/bifidobacterium.html (Accessed May 19, 2016).
55. Everard, A., and Cani, P. D. (2013). Diabetes, obesity and gut microbiota. Best Pract. Res. Clin. Gastroenterol. 27, 73-78. doi: 10.1016/j.bpg.2013.03.007
56. Everard, A., Lazarevic, V., Derrien, M., Girard, M., Muccioli, G. G., Neyrinck, A. M., et al. (2011). Responses of gut microbiota and glucose and lipid metabolism to prebiotics in genetic obese and diet-induced leptin-resistant mice. Diabetes 60, 2775-2786. doi: 10.2337/db11-0227
57. Faith, J. J., Guruge, J. L., Charbonneau, M., Subramanian, S., Seedorf, H., Goodman, A. L., et al. (2013). The long-term stability of the human gut microbiota. Science 341:1237439. doi: 10.1126/science.1237439
58. Falony, G., Calmeyn, T., Leroy, F., and De Vuyst, L. (2009a). Coculture fermentations of Bifidobacterium species and Bacteroides thetaiotaomicron reveal a mechanistic insight into the prebiotic effect of inulin-type fructans. Appl. Environ. Microbiol. 75, 2312-2319. doi: 10.1128/AEM.02649-08
59. Falony, G., Lazidou, K., Verschaeren, A., Weckx, S., Maes, D., and De Vuyst, L. (2009b). In vitro kinetic analysis of fermentation of prebiotic inulin-type fructans by Bifidobacterium species reveals four different phenotypes. Appl. Environ. Microbiol. 75, 454-461. doi: 10.1128/AEM.01488-08
60. Falony, G., Verschaeren, A., De Bruycker, F., De Preter, V., Verbeke, K., Leroy, F., et al. (2009c). In vitro kinetics of prebiotic inulin-type fructan fermentation by butyrate-producing colon bacteria: implementation of online gas chromatography for quantitative analysis of carbon dioxide and hydrogen gas production. Appl. Environ. Microbiol. 75, 5884-5892. doi: 10.1128/AEM.00876-09
61. Falony, G., Vlachou, A., Verbrugghe, K., and De Vuyst, L. (2006). Cross-feeding between Bifidobacterium longum BB536 and acetate-converting, butyrate-producing colon bacteria during growth on oligofructose. Appl. Environ. Microbiol. 72, 7835-7841. doi: 10.1128/AEM.01296-06
62. Figueroa-González, I., Quijano, G., Ramírez, G., and Cruz-Guerrero, A. (2011). Probiotics and prebiotics-perspectives and challenges. J. Sci. Food Agric. 91, 1341-1348. doi: 10.1002/jsfa.4367
63. Frei, R., Akdis, M., and O'Mahony, L. (2015). Prebiotics, probiotics, synbiotics, and the immune system: experimental data and clinical evidence. Curr. Opin. Gastroenterol. 31, 153-158. doi: 10.1097/MOG.0000000000000151
64. Gagnon, M., Savard, P., Rivière, A., LaPointe, G., and Roy, D. (2015). Bioaccessible antioxidants in milk fermented by Bifidobacterium longum subsp. longum strains. Biomed. Res. Int. 2015:169381. doi: 10.1155/2015/169381
65. Geirnaert, A., Steyaert, A., Eeckhaut, V., Debruyne, B., Arends, J. B., Van Immerseel, F., et al. (2014). Butyricicoccus pullicaecorum, a butyrate producer with probiotic potential, is intrinsically tolerant to stomach and small intestine conditions. Anaerobe 30, 70-74. doi: 10.1016/j.anaerobe.2014.08.010
66. Gevers, D., Kugathasan, S., Denson, L. A., Vázquez-Baeza, Y., Van Treuren, W., Ren, B., et al. (2014). The treatment-naive microbiome in new-onset Crohn's disease. Cell Host Microbe 15, 382-392. doi: 10.1016/j.chom.2014.02.005
67. Gibson, G. R., Probert, H. M., Loo, J. V., Rastall, R. A., and Roberfroid, M. B. (2004). Dietary modulation of the human colonic microbiota: updating the concept of prebiotics. Nutr. Res. Rev. 17, 259-275. doi: 10.1079/NRR200479
68. Gibson, G. R., Scott, K. P., Rastall, R. A., Tuohy, K. M., Hotchkiss, A., Dubert-Ferrandon, A., et al. (2010). Dietary prebiotics: current status and new definition. Food Sci. Technol. Bull. 7, 1-19. doi: 10.1616/1476-2137.15880
69. Glanville, J., King, S., Guarner, F., Hill, C., and Sanders, M. E. (2015). A review of the systematic review process and its applicability for use in evaluating evidence for health claims on probiotic foods in the European Union. Nutr. J. 14, 16. doi: 10.1186/s12937-015-0004-5
70. Gorissen, L., De Vuyst, L., Raes, K., De Smet, S., and Leroy, F. (2012). Conjugated linoleic and linolenic acid production kinetics by bifidobacteria differ among strains. Int. J. Food Microbiol. 155, 234-240. doi: 10.1016/j.ijfoodmicro.2012.02.012
71. Gorissen, L., Raes, K., Weckx, S., Dannenberger, D., Leroy, F., De Vuyst, L., et al. (2010). Production of conjugated linoleic acid and conjugated linolenic acid isomers by Bifidobacterium species. Appl. Microbiol. Biotechnol. 87, 2257-2266. doi: 10.1007/s00253-010-2713-1
72. Gosálbez, L., and Ramón, D. (2015). Probiotics in transition: novel strategies. Trends Biotechnol. 33, 195-196. doi: 10.1016/j.tibtech.2015.01.006
73. Gråsten, S., Liukkonen, K. H., Chrevatidis, A., El-Nezami, H., Poutanen, K., and Mykkänen, H. (2003). Effects of wheat pentosan and inulin on the metabolic activity of fecal microbiota and on bowel function in healthy humans. Nutr. Res. 23, 1503-1514. doi: 10.1016/S0271-5317(03)00164-7
74. Grimm, V., Westermann, C., and Riedel, C. U. (2014). Bifidobacteria-host interactions-an update on colonisation factors. Biomed. Res. Int. 2014:960826. doi: 10.1155/2014/960826
75. Grootaert, C., Delcour, J. A., Courtin, C. M., Broekaert, W. F., Verstraete, W., and Van de Wiele, T. (2007). Microbial metabolism and prebiotic potency of arabinoxylan oligosaccharides in the human intestine. Trends Food Sci. Technol. 18, 64-71. doi: 10.1016/j.tifs.2006.08.004
76. Grootaert, C., Van den Abbeele, P., Marzorati, M., Broekaert, W. F., Courtin, C. M., Delcour, J. A., et al. (2009). Comparison of prebiotic effects of arabinoxylan oligosaccharides and inulin in a simulator of the human intestinal microbial ecosystem. FEMS Microbiol. Ecol. 69, 231-242. doi: 10.1111/j.1574-6941.2009.00712.x
77. Gruppen, H., Kormelink, F. J. M., and Voragen, A. G. J. (1993). Enzymic degradation of water-unextractable cell wall material and arabinoxylans from wheat flour. J. Cereal Sci. 18, 129-143. doi: 10.1006/jcrs.1993.1041
78. Hamer, H. M., Jonkers, D., Venema, K., Vanhoutvin, S., Troost, F. J., and Brummer, R. J. (2008). Review article: the role of butyrate on colonic function. Aliment. Pharmacol. Ther. 27, 104-119. doi: 10.1111/j.1365-2036.2007.03562.x
79. Havenaar, R. (2011). Intestinal health functions of colonic microbial metabolites: a review. Benef. Microbes 2, 103-114. doi: 10.3920/BM2011.0003
80. Hill, C., Guarner, F., Reid, G., Gibson, G. R., Merenstein, D. J., Pot, B., et al. (2014). Expert consensus document. The International Scientific Association for Probiotics and Prebiotics consensus statement on the scope and appropriate use of the term probiotic. Nat. Rev. Gastroenterol. Hepatol. 11, 506-514. doi: 10.1038/nrgastro.2014.66
81. Hood, L. (2012). Tackling the microbiome. Science 336, 1209. doi: 10.1126/science.1225475
82. Hopkins, M. J., Englyst, H. N., Macfarlane, S., Furrie, E., Macfarlane, G. T., and McBain, A. J. (2003). Degradation of cross-linked and non-cross-linked arabinoxylans by the intestinal microbiota in children. Appl. Environ. Microbiol. 69, 6354-6360. doi: 10.1128/AEM.69.11.6354-6360.2003
83. Hughes, S. A., Shewry, P. R., Li, L., Gibson, G. R., Sanz, M. L., and Rastall, R. A. (2007). In vitro fermentation by human fecal microflora of wheat arabinoxylans. J. Agric. Food Chem. 55, 4589-4595. doi: 10.1021/jf070293g
84. Hutkins, R. W., Krumbeck, J. A., Bindels, L. B., Cani, P. D., Fahey, G., Goh, Y. J., et al. (2016). Prebiotics: why definitions matter. Curr. Opin. Biotechnol. 37, 1-7. doi: 10.1016/j.copbio.2015.09.001
85. Ishikawa, E., Matsuki, T., Kubota, H., Makino, H., Sakai, T., Oishi, K., et al. (2013). Ethnic diversity of gut microbiota: species characterization of Bacteroides fragilis group and genus Bifidobacterium in healthy Belgian adults, and comparison with data from Japanese subjects. J. Biosci. Bioeng. 116, 265-270. doi: 10.1016/j.jbiosc.2013.02.010
86. Izydorczyk, M. S., and Biliaderis, C. G. (1995). Cereal arabinoxylans: advances in structure and physicochemical properties. Carbohydr. Polym. 28, 33-48. doi: 10.1016/0144-8617(95)00077-1
87. Izydorczyk, M. S., and Biliaderis, C. G. (2006). "Arabinoxylans: technology and nutritionally functional plant polysaccharides, "in Functional Food Carbohydrates, eds C. G. Biliaderis and M. S. Izydorczyk (Boca Raton, FL: CRC Press), 249-290.
88. Jedrzejczak-Krzepkowska, M., Tkaczuk, K. L., and Bielecki, S. (2011). Biosynthesis, purification and characterization of β-fructofuranosidase from Bifidobacterium longum KN29.1. Proc. Biochem. 46, 1963-1972. doi: 10.1016/j.procbio.2011.07.005
89. Kapel, N., Thomas, M., Corcos, O., Mayeur, C., Barbot-Trystram, L., Bouhnik, Y., et al. (2014). Practical implementation of faecal transplantation. Clin. Microbiol. Infec. 20, 1098-1105. doi: 10.1111/1469-0691.12796
90. Khodayar-Pardo, P., Mira-Pascual, L., Collado, M. C., and Martínez-Costa, C. (2014). Impact of lactation stage, gestational age and mode of delivery on breast milk microbiota. J. Perinatol. 34, 599-605. doi: 10.1038/jp.2014.47
91. Klijn, A., Mercenier, A., and Arigoni, F. (2005). Lessons from the genomes of bifidobacteria. FEMS Microbiol. Rev. 29, 491-509. doi: 10.1016/j.fmrre.2005.04.010
92. Kumar, H., Salminen, S., Verhagen, H., Rowland, I., Heimbach, J., Bañares, S., et al. (2015). Novel probiotics and prebiotics: road to the market. Curr. Opin. Biotechnol. 32, 99-103. doi: 10.1016/j.copbio.2014.11.021
93. Lagaert, S., Pollet, A., Courtin, C. M., and Volckaert, G. (2014). β-Xylosidases and a-L-arabinofuranosidases: accessory enzymes for arabinoxylan degradation. Biotechnol. Adv. 32, 316-332. doi: 10.1016/j.biotechadv.2013.11.005
94. Lagaert, S., Pollet, A., Delcour, J. A., Lavigne, R., Courtin, C. M., and Volckaert, G. (2010). Substrate specificity of three recombinant a-L-arabinofuranosidases from Bifidobacterium adolescentis and their divergent action on arabinoxylan and arabinoxylan oligosaccharides. Biochem. Biophys. Res. Commun. 26, 644-650. doi: 10.1016/j.bbrc.2010.10.075
95. Lagaert, S., Pollet, A., Delcour, J. A., Lavigne, R., Courtin, C. M., and Volckaert, G. (2011). Characterization of two β-xylosidases from Bifidobacterium adolescentis and their contribution to the hydrolysis of prebiotic xylooligosaccharides. Appl. Microbiol. Biotechnol. 92, 1179-1185. doi: 10.1007/s00253-011-3396-y
96. Laureys, D., Cnockaert, M., De Vuyst, L., and Vandamme, P. (2016). Bifidobacterium aquikefiri sp. nov., isolated from water kefir. Int. J. Syst. Evolut. Microbiol. 66, 1281-1286. doi: 10.1099/ijsem.0.000877
97. Laureys, D., and De Vuyst, L. (2014). Microbial species diversity, community dynamics, and metabolite kinetics of water kefir fermentation. Appl. Environ. Microbiol. 80, 2564-2572. doi: 10.1128/AEM.03978-13
98. Leahy, S. C., Higgins, D. G., Fitzgerald, G. F., and van Sinderen, D. (2005). Getting better with bifidobacteria. J. Appl. Microbiol. 98, 1303-1315. doi: 10.1111/j.1365-2672.2005.02600.x
99. Le Chatelier, E., Nielsen, T., Qin, J., Prifti, E., Hildebrand, F., Falony, G., et al. (2013). Richness of human gut microbiome correlates with metabolic markers. Nature 500, 541-546. doi: 10.1038/nature12506
100. Li, S., Zhu, A., Benes, V., Costea, P. I., Hercog, R., Hildebrand, F., et al. (2016). Durable coexistence of donor and recipient strains after fecal microbiota transplantation. Science 352, 586-589. doi: 10.1126/science.aad8852
101. Lombard, V., Ramulu, H. G., Drula, E., Coutinho, P. M., and Henrissat, B. (2014). The carbohydrate-active enzymes database (CAZy) in 2013. Nucleic Acids Res. 42, D490-D495. doi: 10.1093/nar/gkt1178
102. Louis, P., and Flint, H. J. (2009). Diversity, metabolism and microbial ecology of butyrate-producing bacteria from the human large intestine. FEMS Microbiol. Lett. 294, 1-8. doi: 10.1111/j.1574-6968.2009.01514.x
103. Louis, P., Hold, G. L., and Flint, H. J. (2014). The gut microbiota, bacterial metabolites and colorectal cancer. Nat. Rev. Microbiol. 12, 661-672. doi: 10.1038/nrmicro3344
104. Macfarlane, G. T., and Macfarlane, S. (2012). Bacteria, colonic fermentation, and gastrointestinal health. J. AOAC Int. 95, 50-60. doi: 10.5740/jaoacint. SGE_Macfarlane
105. Macfarlane, G. T., Steed, H., and Macfarlane, S. (2008). Bacterial metabolism and health-related effects of galacto-oligosaccharides and other prebiotics. J. Appl. Microbiol. 104, 305-344. doi: 10.1111/j.1365-2672.2007.03520.x
106. Maes, C., and Delcour, J. A. (2002). Structural characterisation of water-extractable and water-unextractable arabinoxylans in wheat bran. J. Cereal Sci. 35, 315-326. doi: 10.1006/jcrs.2001.0439
107. Mahowald, M. A., Rey, F. E., Seedorf, H., Turnbaugh, P. J., Fulton, R. S., Wollam, A., et al. (2009). Characterizing a model human gut microbiota composed of members of its two dominant bacterial phyla. Proc. Natl. Acad. Sci. U.S.A. 106, 5859-5864. doi: 10.1073/pnas.0901529106
108. Maki, K. C., Gibson, G. R., Dickmann, R. S., Kendall, C. W., Chen, C. Y., Costabile, A., et al. (2012). Digestive and physiologic effects of a wheat bran extract, arabino-xylan-oligosaccharide, in breakfast cereal. Nutrition 28, 1115-1121. doi: 10.1016/j.nut.2012.02.010
109. Marchesi, J. R., Holmes, E., Khan, F., Kochhar, S., Scanlan, P., Shanahan, F., et al. (2007). Rapid and noninvasive metabonomic characterization of inflammatory bowel disease. J. Proteome Res. 6, 546-551. doi: 10.1021/pr060470d
110. Marteau, P. (2013). Butyrate-producing bacteria as pharmabiotics for inflammatory bowel disease. Gut 62, 1673. doi: 10.1136/gutjnl-2012-304240
111. Martín, R., Miquel, S., Chain, F., Natividad, J. M., Jury, J., Lu, J., et al. (2015). Faecalibacterium prausnitzii prevents physiological damages in a chronic low-grade inflammation murine model. BMC Microbiol. 15:67. doi: 10.1186/s12866-015-0400-1
112. McLaughlin, H. P., Motherway, M. O., Lakshminarayanan, B., Stanton, C., Paul Ross, R., Brulc, J., et al. (2015). Carbohydrate catabolic diversity of bifidobacteria and lactobacilli of human origin. Int. J. Food Microbiol. 203, 109-121. doi: 10.1016/j.ijfoodmicro.2015.03.008
113. Mendis, M., and Simsek, S. (2013). Arabinoxylans and human health. Food Hydrocoll. 42, 239-243. doi: 10.1016/j.foodhyd.2013.07.022
114. Miquel, S., Martín, R., Bridonneau, C., Robert, V., Sokol, H., Bermúdez-Humarán, L. G., et al. (2014). Ecology and metabolism of the beneficial intestinal commensal bacterium Faecalibacterium prausnitzii. Gut Microbes 5, 146-151. doi: 10.4161/gmic.27651
115. Moens, F., Weckx, S., and De Vuyst, L. (2016). Bifidobacterial inulin-type fructan degradation capacity determines cross-feeding interactions between bifidobacteria and Faecalibacterium prausnitzii. Int. J. Food Microbiol. 231, 76-85 doi: 10.1016/j.ijfoodmicro.2016.05.015
116. Morgan, X. C., Tickle, T. L., Sokol, H., Gevers, D., Devaney, K. L., Ward, D. V., et al. (2012). Dysfunction of the intestinal microbiome in inflammatory bowel disease and treatment. Genome Biol. 13:R79. doi: 10.1186/gb-2012-13-9-r79
117. NCBI Resource Coordinators (2014). Database resources of the National Center for Biotechnology Information. Nucleic Acids Res. 42, D7-D17. doi: 10.1093/nar/gkt1146
118. Nemoto, H., Kataoka, K., Ishikawa, H., Ikata, K., Arimochi, H., Iwasaki, T., et al. (2012). Reduced diversity and imbalance of fecal microbiota in patients with ulcerative colitis. Dig. Dis. Sci. 57, 2955-2964. doi: 10.1007/s10620-012-2236-y
119. Neyrinck, A. M., Possemiers, S., Druart, C., van de Wiele, T., De Backer, F., Cani, P. D., et al. (2011). Prebiotic effects of wheat arabinoxylan related to the increase in bifidobacteria, Roseburia and Bacteroides/Prevotella in diet-induced obese mice. PLoS ONE 6:e20944. doi: 10.1371/journal.pone.0020944
120. Neyrinck, A. M., Van Hée, V. F., Piront, N., De Backer, F., Toussaint, O., Cani, P. D., et al. (2012). Wheat-derived arabinoxylan oligosaccharides with prebiotic effect increase satietogenic gut peptides and reduce metabolic endotoxemia in diet-induced obese mice. Nutr. Diabetes 2, e28. doi: 10.1038/nutd.2011.24
121. Nielsen, T. S., Lærke, H. N., Theil, P. K., Sørensen, J. F., Saarinen, M., Forssten, S., et al. (2014). Diets high in resistant starch and arabinoxylan modulate digestion processes and SCFA pool size in the large intestine and faecal microbial composition in pigs. Br. J. Nutr. 112, 1837-1849. doi: 10.1017/S000711451400302X
122. O'Hara, A. M., and Shanahan, F. (2006). The gut flora as a forgotten organ. EMBO Rep. 7, 688-693. doi: 10.1038/sj.embor.7400731
123. Omori, T., Ueno, K., Muramatsu, K., Kikuchi, M., Onodera, S., and Shiomi, N. (2010). Characterization of recombinant β-fructofuranosidase from Bifidobacterium adolescentis G1. Chem. Centr. J. 4:9. doi: 10.1186/1752-153X-4-9
124. Ou, J., and Sun, Z. (2014). Feruloylated oligosaccharides: structure, metabolism and function. J. Funct. Foods 7, 90-100. doi: 10.1016/j.jff.2013.09.028
125. Palframan, R. J., Gibson, G. R., and Rastall, R. A. (2003). Carbohydrate preferences of Bifidobacterium species isolated from the human gut. Curr. Issues Intest. Microbiol. 4, 71-75.
126. Pamer, E. G. (2014). Fecal microbiota transplantation: effectiveness, complexities, and lingering concerns. Mucosal Immunol. 7, 210-214. doi: 10.1038/mi.2013.117
127. Parche, S., Amon, J., Jankovic, I., Rezzonico, E., Beleut, M., Barutcu, H., et al. (2007). Sugar transport systems of Bifidobacterium longum NCC2705. J. Mol. Microbiol. Biotechnol. 12, 9-19. doi: 10.1159/000096455
128. Pastell, H., Westermann, P., Meyer, A. S., Tuomainen, P., and Tenkanen, M. (2009). In vitro fermentation of arabinoxylan-derived carbohydrates by bifidobacteria and mixed faecal microbiota. J. Agric. Food Chem. 57, 8598-8606. doi: 10.1021/jf901397b
129. Pokusaeva, K., Fitzgerald, G. F., and van Sinderen, D. (2011). Carbohydrate metabolism in Bifidobacteria. Genes Nutr. 6, 285-306. doi: 10.1007/s12263-010-0206-6
130. Pollet, A., Van Craeyveld, V., Van de Wiele, T., Verstraete, W., Delcour, J. A., and Courtin, C. M. (2012). In vitro fermentation of arabinoxylan oligosaccharides and low molecular mass arabinoxylans with different structural properties from wheat (Triticum aestivum L.) bran and psyllium (Plantago ovata Forsk) seed husk. J. Agric. Food Chem. 60, 946-954. doi: 10.1021/jf203820j
131. The Human Microbiome Project Consortium (2012). Structure, function and diversity of the healthy human microbiome. Nature 486, 207-214. doi: 10.1038/nature11234
132. Qiu, X., Zhang, M., Yang, X., Hong, N., and Yu, C. (2013). Faecalibacterium prausnitzii upregulates regulatory T cells and anti-inflammatory cytokines in treating TNBS-induced colitis. J. Crohns Colitis 7, e558-e568. doi: 10.1016/j.crohns.2013.04.002
133. Quévrain, E., Maubert, M. A., Michon, C., Chain, F., Marquant, R., Tailhades, J., et al. (2016). Identification of an anti-inflammatory protein from Faecalibacterium prausnitzii, a commensal bacterium deficient in Crohn's disease. Gut 65, 415-425. doi: 10.1136/gutjnl-2014-307649
134. Richards, L. B., Li, M., van Esch, B. C. A. M., Garssen, J., and Folkerts, G. (2016). The effects of short-chain fatty acids on the cardiovascular system. Pharma Nutr. 4, 68-111. doi: 10.1016/j.phanu.2016.02.001
135. Ridaura, V. K., Faith, J. J., Rey, F. E., Cheng, J., Duncan, A. E., Kau, A. L., et al. (2013). Gut microbiota from twins discordant for obesity modulate metabolism in mice. Science 341:1241214. doi: 10.1126/science.1241214
136. Rivière, A., Gagnon, M., Weckx, S., Roy, D., and De Vuyst, L. (2015). Mutual cross-feeding interactions between Bifidobacterium longum NCC2705 and Eubacterium rectale ATCC 33656 explain the bifidogenic and butyrogenic effects of arabinoxylan-oligosaccharides. Appl. Environ. Microbiol. 81, 7767-7781. doi: 10.1128/AEM.02089-15
137. Rivière, A., Moens, F., Selak, M., Maes, D., Weckx, S., and De Vuyst, L. (2014). The ability of bifidobacteria to degrade arabinoxylan oligosaccharide constituents and derived oligosaccharides is strain dependent. Appl. Environ. Microbiol. 80, 204-217. doi: 10.1128/AEM.02853-13
138. Roberfroid, M. B. (2005). Introducing inulin-type fructans. Br. J. Nutr. 93, S13-S25. doi: 10.1079/bjn20041350
139. Roberfroid, M. B. (2007). Inulin-type fructans: functional food ingredients. J. Nutr. 137, 2493-2502. doi: 10.1201/9780203504932
140. Rossi, M., and Amaretti, A. (2011). "Probiotic properties of bifidobacteria" in Bifidobacteria, Genomics and Molecular Aspects, eds B. Mayo and D. van Sinderen (Norwich: Caister Academic Press), 97-123.
141. Saez-Lara, M. J., Gomez-Llorente, C., Plaza-Diaz, J., and Gil, A. (2015). The role of probiotic lactic acid bacteria and bifidobacteria in the prevention and treatment of inflammatory bowel disease and other related diseases: a systematic review of randomized human clinical trials. Biomed. Res. Int. 2015:505878. doi: 10.1155/2015/505878
142. Salminen, S., and van Loveren, H. (2012). Probiotics and prebiotics: health claim substantiation. Microb. Ecol. Health Dis. 23:18568. doi: 10.3402/mehd.v23i0.18568
143. Sanchez, J. I., Marzorati, M., Grootaert, C., Baran, M., Van Craeyveld, V., Courtin, C. M., et al. (2009). Arabinoxylan-oligosaccharides (AXOS) affect the protein/carbohydrate fermentation balance and microbial population dynamics of the simulator of human intestinal microbial ecosystem. Microb. Biotechnol. 2, 101-113. doi: 10.1111/j.1751-7915.2008.00064.x
144. Schaafsma, G., and Slavin, J. L. (2015). Significance of inulin fructans in the human diet. Compr. Rev. Food Sci. Food Saf. 14, 37-47. doi: 10.1111/1541-4337.12119
145. Schell, M. A., Karmirantzou, M., Snel, B., Vilanova, D., Berger, B., Pessi, G., et al. (2002). The genome sequence of Bifidobacterium longum reflects its adaptation to the human gastrointestinal tract. Proc. Natl. Acad. Sci. U.S.A. 99, 14422-14427. doi: 10.1073/pnas.212527599
146. Scott, K. P., Antoine, J. M., Midtvedt, T., and van Hemert, S. (2015). Manipulating the gut microbiota to maintain health and treat disease. Microb. Ecol. Health Dis. 26, 25877. doi: 10.3402/mehd.v26.25877
147. Scott, K. P., Martin, J. C., Chassard, C., Clerget, M., Potrykus, J., Campbell, G., et al. (2011). Substrate-driven gene expression in Roseburia inulinivorans: importance of inducible enzymes in the utilization of inulin and starch. Proc. Natl. Acad. Sci. U.S.A. 1, 4672-4679. doi: 10.1073/pnas.1000091107
148. Scott, K. P., Martin, J. C., Duncan, S. H., and Flint, H. J. (2014). Prebiotic stimulation of human colonic butyrate-producing bacteria and bifidobacteria, in vitro. FEMS Microbiol. Ecol. 87, 30-40. doi: 10.1111/1574-6941.12186
149. Selak, M., Rivière, A., Moens, F., Van den Abbeele, P., Geirnaert, A., Rogelj, I., et al. (2016). Inulin-type fructan fermentation by bifidobacteria depends on the strain rather than the species and region in the human intestine. Appl. Microbiol. Biotechnol. 100, 4097-4107. doi: 10.1007/s00253-016-7351-9
150. Sharon, G., Garg, N., Debelius, J., Knight, R., Dorrestein, P. C., and Mazmanian, S. K. (2014). Specialized metabolites from the microbiome in health and disease. Cell Metab. 20, 719-730. doi: 10.1016/j.cmet.2014.10.016
151. Slavin, J. (2013). Fiber and prebiotics: mechanisms and health benefits. Nutrients 5, 1417-1435. doi: 10.3390/nu5041417
152. Snelders, J., Olaerts, H., Dornez, E., Van de Wiele, T., Aura, A. M., Vanhaecke, L., et al. (2014). Structural features and feruloylation modulate the fermentability and evolution of antioxidant properties of arabinoxylanoligosaccharides during in vitro fermentation by human gut derived microbiota. J. Funct. Foods 10, 1-12. doi: 10.1016/j.jff.2014.05.011
153. Sommer, F., and Bäckhed, F. (2013). The gut microbiota-masters of host development and physiology. Nat. Rev. Microbiol. 11, 227-238. doi: 10.1038/nrmicro2974
154. Swennen, K., Courtin, C. M., Lindemans, G. C. J. E., and Delcour, J. A. (2006). Large-scale production and characterisation of wheat bran arabinoxylooligosaccharides. J. Sci. Food Agric. 86, 1722-1731. doi: 10.1002/jsfa.2470
155. Tannock, G. W. (2010). "Analysis of bifidobacterial populations in bowel ecology studies" in Bifidobacteria, Genomics and Molecular Aspects, eds B. Mayo and D. van Sinderen (Norwich: Caister Academic Press), 1-15.
156. Tap, J., Mondot, S., Levenez, F., Pelletier, E., Caron, C., Furet, J. P., et al. (2009). Towards the human intestinal microbiota phylogenetic core. Environ. Microbiol. 11, 2574-2584. doi: 10.1111/j.1462-2920.2009.01982.x
157. Tojo, R., Suárez, A., Clemente, M. G., de los Reyes-Gavilán, C. G., Margolles, A., Gueimonde, M., et al. (2014). Intestinal microbiota in health and disease: role of bifidobacteria in gut homeostasis. World J. Gastroenterol. 20, 15163-15176. doi: 10.3748/wjg.v20.i41.15163
158. Tralongo, P., Tomasello, G., Sinagra, E., Damiani, P., Leone, A., Palumbo, V. D., et al. (2014). The role of butyric acid as a protective agent against inflammatory bowel diseases. Euromediterranean Biomed. J. 9, 24-35. doi: 10.3269/1970-5492.2014.9.4
159. Tuohy, K. M., and Scott, K. P. (2015). "The microbiota of the human gastrointestinal tract: a molecular view" in Diet-Microbe Interactions in the Gut, eds K. M. Tuohy and D. Del Rio (London: Elsevier), 1-15.
160. Turroni, F., Özcan, E., Milani, C., Mancabelli, L., Viappiani, A., van Sinderen, D., et al. (2015). Glycan cross-feeding activities between bifidobacteria under in vitro conditions. Front. Microbiol. 6:1030. doi: 10.3389/fmicb.2015.01030
161. Turroni, F., Foroni, E., Pizzetti, P., Giubellini, V., Ribbera, A., Merusi, P., et al. (2009). Exploring the diversity of the bifidobacterial population in the human intestinal tract. Appl. Environ. Microbiol. 75, 1534-1545. doi: 10.1128/AEM.02216-08
162. Turroni, F., Peano, C., Pass, D. A., Foroni, E., Severgnini, M., Claesson, M. J., et al. (2012). Diversity of bifidobacteria within the infant gut microbiota. PLoS ONE 7:e36957. doi: 10.1371/journal.pone.0036957
163. Van Craeyveld, V., Swennen, K., Dornez, E., Van de Wiele, T., Marzorati, M., Verstraete, W., et al. (2008). Structurally different wheat-derived arabinoxylooligosaccharides have different prebiotic and fermentation properties in rats. J. Nutr. 138, 2348-2355. doi: 10.3945/jn.108.094367
164. Van den Abbeele, P., Belzer, C., Goossens, M., Kleerebezem, M., De Vos, W. M., Thas, O., et al. (2013a). Butyrate-producing Clostridium cluster XIVa species specifically colonize mucins in an in vitro gut model. ISME J. 7, 949-961. doi: 10.1038/ismej.2012.158
165. Van den Abbeele, P., Gerard, P., Rabot, S., Bruneau, A., El Aidy, S., Derrien, M., et al. (2011). Arabinoxylans and inulin differentially modulate the mucosal and luminal gut microbiota and mucin-degradation in humanized rats. Environ. Microbiol. 13, 2667-2680. doi: 10.1111/j.1462-2920.2011.02533.x
166. Van den Abbeele, P., Verstraete, W., El Aidy, S., Geirnaert, A., and Van de Wiele, T. (2013b). Prebiotics, faecal transplants and microbial network units to stimulate biodiversity of the human gut microbiome. Microb. Biotechnol. 6, 335-340. doi: 10.1111/1751-7915.12049
167. van den Broek, L. A. M., Hinz, S. W. A., Beldman, G., Vincken, J. P., and Voragen, A. G. J. (2008). Bifidobacterium carbohydrases-their role in breakdown and synthesis of (potential) prebiotics. Nutr. Food. Res. 52, 146-163. doi: 10.1002/mnfr.200700121
168. van den Broek, L. A. M., and Voragen, A. G. J. (2008). Bifidobacterium glycoside hydrolases and (potential) prebiotics. Innov. Food Sci. Emerg. Technol. 9, 401-407. doi: 10.1016/j.ifset.2007.12.006
169. Van der Meulen, R., Adriany, T., Verbrugghe, K., and De Vuyst, L. (2006a). Kinetic analysis of bifidobacterial metabolism reveals a minor role for succinic acid in the regeneration of NAD+ through its growth-associated production. Appl. Environ. Microbiol. 72, 5204-5210. doi: 10.1128/AEM.00146-06
170. Van der Meulen, R., Avonts, L., and De Vuyst, L. (2004). Short fractions of oligofructose are preferentially metabolized by Bifidobacterium animalis DN-173 010. Appl. Environ. Microbiol. 70, 1923-1930. doi: 10.1128/AEM.70.4.1923-1930.2004
171. Van der Meulen, R., Makras, L., Verbrugghe, K., Adriany, T., and De Vuyst, L. (2006b). In vitro kinetic analysis of oligofructose consumption by Bacteroides and Bifidobacterium spp. indicates different degradation mechanisms. Appl. Environ. Microbiol. 72, 1006-1012. doi: 10.1128/AEM.72.2.1006-1012.2006
172. Van Laere, K. M. J., Hartemink, R., Bosveld, M., Schols, H. A., and Voragen, A. G. J. (2000). Fermentation of plant cell wall derived polysaccharides and their corresponding oligosaccharides by intestinal bacteria. J. Agric. Food Chem. 48, 1644-1652. doi: 10.1021/jf990519i
173. Velasquez-Manoff, M. (2015). Gut microbiome: the peacekeepers. Nature 518, S3-S11. doi: 10.1038/518S3a
174. Ventura, M., O'Flaherty, S., Claesson, M. J., Turroni, F., Klaenhammer, T. R., van Sinderen, D., et al. (2009). Genome-scale analyses of health-promoting bacteria: probiogenomics. Nat. Rev. Microbiol. 7, 61-71. doi: 10.1038/nrmicro2047
175. Ventura, M., Turroni, F., Bottacini, F., Giubellini, V., and van Sinderen, D. (2011). "Bifidobacterial ecology and comparative genomics: perspectives and prospects, "in Bifidobacteria, Genomics and Molecular Aspects, eds B. Mayo and D. van Sinderen (Norwich: Caister Academic Press), 31-44.
176. Ventura, M., Turroni, F., Lugli, G. A., and van Sinderen, D. (2014). Bifidobacteria and humans: our special friends, from ecological to genomics perspectives. J. Sci. Food Agric. 94, 163-168. doi: 10.1002/jsfa.6356
177. Verbeke, K. (2014). "Prebiotics and synbiotics: how do they affect health?" in Clinical Insights: Probiotics, Prebiotics and Gut Health, eds M. H. Floch and A. Kim (London: Future Medicine Ltd.), 47-61.
178. Verspreet, J., Damen, D., Broekaert, W. F., Verbeke, K., Delcour, J. A., and Courtin, C. M. (2016). A critical look at prebiotics within the dietary fiber concept. Annu. Rev. Food Sci. Technol. 7, 167-190. doi: 10.1146/annurev-food-081315-032749
179. Vital, M., Howe, A. C., and Tiedje, J. M. (2014). Revealing the bacterial butyrate synthesis pathways by analyzing (meta)genomic data. MBio 5, e00889-e00814. doi: 10.1128/mBio.00889-14
180. Vrieze, A., Van Nood, E., Holleman, F., Salojärvi, J., Kootte, R. S., Bartelsman, J. F., et al. (2012). Transfer of intestinal microbiota from lean donors increases insulin sensitivity in individuals with metabolic syndrome. Gastroenterology 143, 913-916. doi: 10.1053/j.gastro.2012.06.031
181. Walker, A. W., Duncan, S. H., Louis, P., and Flint, H. J. (2014). Phylogeny, culturing, and metagenomics of the human gut microbiota. Trends Microbiol. 22, 267-274. doi: 10.1016/j.tim.2014.03.001
182. Walton, G. E., Lu, C., Trogh, I., Arnaut, F., and Gibson, G. R. (2012). A randomised, double-blind, placebo controlled cross-over study to determine the gastrointestinal effects of consumption of arabinoxylan-oligosaccharides enriched bread in healthy volunteers. Nutr. J. 11:36. doi: 10.1186/1475-2891-11-36
183. Warchol, M., Perrin, S., Grill, J. P., and Schneider, F. (2002). Characterization of a purified beta-fructofuranosidase from Bifidobacterium infantis ATCC 15697. Lett. Appl. Microbiol. 35, 462-467. doi: 10.1046/j.1472-765X.2002.01224.x
184. Whitman, W. B., Coleman, D. C., and Wiebe, W. J. (1998). Prokaryotes: the unseen majority. Proc. Natl. Acad. Sci. U.S.A. 95, 6578-6583. doi: 10.1073/pnas.95.12.6578
185. Wikoff, W. R., Anfora, A. T., Liu, J., Schultz, P. G., Lesley, S. A., Peters, E. C., et al. (2009). Metabolomics analysis reveals large effects of gut microflora on mammalian blood metabolites. Proc. Natl. Acad. Sci. U.S.A. 106, 3698-3703. doi: 10.1073/pnas.0812874106
186. Wu, N., Yang, X., Zhang, R., Li, J., Xiao, X., Hu, Y., et al. (2013). Dysbiosis signature of fecal microbiota in colorectal cancer patients. Microb. Ecol. 66, 462-470. doi: 10.1007/s00248-013-0245-9
187. Xu, M. Q., Cao, H. L., Wang, W. Q., Wang, S., Cao, X. C., Yan, F., et al. (2015). Fecal microbiota transplantation broadening its application beyond intestinal disorders. World J. Gastroenterol. 21, 102-111. doi: 10.3748/wjg.v21.i1.102
188. Yang, J., Martínez, I., Walter, J., Keshavarzian, A., and Rose, D. J. (2013). In vitro characterization of the impact of selected dietary fibers on fecal microbiota composition and short chain fatty acid production. Anaerobe 23, 74-81. doi: 10.1016/j.anaerobe.2013.06.012
189. Zoetendal, E. G., Raes, J., van den Bogert, B., Arumugam, M., Booijink, C. C., Troost, F. J., et al. (2012). The human small intestinal microbiota is driven by rapid uptake and conversion of simple carbohydrates. ISME J. 6, 1415-1426. doi: 10.1038/ismej.2011.212